Friday, March 21, 2008

eFoodSafety Formulates All-Natural Antibiotic ``Proxorin(TM)''




eFoodSafety.com, Inc. (OTCBB: EFSF, ), through its wholly-owned
subsidiary Knock-Out Technologies Ltd., have industrialized and
will initiate clinical conducting tests of Proxorin, end on top
of the company's CitroxinTM procedure, contained via approve of
consumption in placement of a unprocessed
antibiotic/anti-microbial for psychotherapy obstreperous a vast
spectrum of established bacterial pathogens. Unlike lots
antibiotics, which recurrently relevant a petite lace of
application, Proxorin's natural career allows it to be previously
owned in a range of provisions where on earth anti-microbials be
needed.



As an antibiotic, Proxorin can submission several advantages done
common drug-based antibiotics. Its proficiency to confer its
benefits against both gram-negative and gram-positive germs
enable it to be used to satisfaction a broad spectrum of
bacterial pathogens. Proxorin also cultivate far a lower amount
of sideways effects than other common antibiotic pharmaceuticals,
thereby reducing the odds of shrink from infection. In mixing,
Proxorin can distinction benefits to those patients who endure
allergic reaction to a spectrum of "cillin" drugs. Finally, an
colossal riddle for the standard armament of antibiotics be the
soon-to-be for "bugs" to change disagreement to the beneficent
effects of a given antibiotic-a scenario that is to read out
notably questioning to lug place next to Proxorin.



Any translation of insulin dose should be made vigilantly and
only beneath medical overseeing. Levemir should not be diluted or
various with any other insulin preparations or used in insulin
infusion pump. Whether the observed difference in weight mean
true differences in the effects of Levemir and NPH insulin is not
prearranged, since these trials were not unsighted and the
protocols (e.g., diet and breaking in remit and monitoring) were
not definitely directed at explore hypothesis connected to weight
effects of the treatments compare. The clinical value of the
observed differences has not be demonstrated.



"The declaration to conduct clinical testing of Proxorin as a
natural antibiotic is based on the encouraging microbial
inhibition keep an eye on grades showing its ability to eradicate
MRSA as other common bacterial pathogens," say Robert Bowker,
President of Knock-Out Technologies. "These indiscriminate
bacterial pathogens are becoming gradually knotty and dear to
licking using appointed pharmaceutical method. Importantly,
eFoodSafety can offer Proxorin as both a high potency pill for
oral ingestion and as a trans-dermal cream that provide effective
digestion short be in somebody`s debt to transfer through normal
digestion. We get the drift that with afloat clinical results,
our natural treatment can provide a supervisor cure to patients
seeking treatment." About eFoodSafety.com, Inc.



efoodsafety.com, Inc. is predictable to on an upward curve form
conditions on all side the world through its ultramodern
technology. The company's Knock-Out Technologies, Ltd. subsidiary
has developed an environmentally past the worst sporicidal goods
formulate entirely of food-grade components that eradicate
anthrax and a germicidal product, Citroxin (formerly pet name Big
Six Plus) - EPA Reg. No. 82723-1 that kill six major bacteria:
E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and
Streptococcus, Avian Influenza, and Black Mold. The sporicidal
product has completed its finishing efficacy laboratory
examination requisite for EPA registration. In the study, it
eradicate both Clostridium Sporogenes and Bacillus Subtilis with
100% efficacy on both frozen and spongy side. The OraPhyte
product, which has be tested and shown to be effective at
eradicating nematodes by the U.S. Department of Agriculture, is
now at three major university with incomparable Agricultural
Departments endure crop-specific research.



The Company is the sumptuousness controller of Cinnergen, a
clinically-studied, non-prescription fluid unharmed diet food
adjunct that promote decent glucose metabolism accessible for
mart at () and through national retailer; and Cinnechol, a
multi-faceted dietetic supplement definitely designed to innately
lessen undiluted cholesterol level gratuitously any side effects.
The Company has enter into a shared endeavour agreement with CK41
Direct, Inc. to launch the PurEffect anti-acne wrapping
fastidiousness convention.



The company's iBoost, Inc. subsidiary is the point of the Immune
Boost Bar, a non-dairy, no graceful sugar, all-natural and
infinite multi-nutrient product that relieve fortify the body's
immune system. The product contain Citroxin, eFoodSafety's
proprietary all natural supplement proven effective in aggression
several sort of insalubrious bacteria, and forty active compounds
that facilitate with enhancing imperviousness, detoxification,
decontamination, and metabolic efficacy. The Immune Boost Bar is
available in three mouth-watering flavors: sunburn,
oatmeal-raisin, and orange-apple and can be purchase at The
company's MedElite, Inc. subsidiary distributes clinically proven
products to physician who next prescribe the products for their
patients. It of belatedly now become the owner of the
Talsyn-CI/bid Scar Cream, that has been clinically proven to
facilitate and amend the demeanour, flush and physique of scar
(), as all right as seven (7) other products in the Talsyn
manacle.



Please call upon in the Company's website at: Safe Harbor
Forward-Looking Statements Statements contained here release that
are not in precept historical are "forward-looking order." Such
forward-looking statements are sometimes identified by libretto
such as "intends," "anticipates," "believes," "expects" and
"hopes." The forward-looking statements are made based on rumour
available commencing the date hereof, and the Company assume no
what you have to do to update such forward-looking statements.
Editors and saver are caution that such forward-looking
statements mix up with risk and uncertainties that could
explanation the Company's actual results to diverge materially
from those in these forward-looking statements. Such risks and
uncertainties consist of but are not limited to emergency for the
Company's products and services, our ability to keep trying to
develop market, important trade and industry conditions, our
ability to out of harm`s way other finance for the Company and
other factor that may be more fully gluey label in reports to
shareholders and sporadic filings with the Securities and
Exchange Commission.




Read details about bone spurs on AmPills.com




Medicine herbal medicine
- new features.



0 comments: